EQUITY RESEARCH MEMO

Sintetica

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)40/100

Sintetica is a Swiss pharmaceutical company established in 1921, specializing in the development and manufacturing of sterile injectable solutions for anesthesia, analgesia, pain management, intensive care, and neuromodulation. The company operates two production facilities in Switzerland, focusing on high-quality ampoules, vials, and infusion bags, with a workforce of approximately 300 employees. Its mission is to improve therapies through innovative drug formulations driven by clinical insights. With over a century of experience, Sintetica has built a reputation for quality and reliability in the injectable pharmaceuticals market, primarily serving Europe and potentially expanding globally. The company remains private and does not disclose financials or pipeline details, limiting visibility into near-term growth drivers.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)